Laxxon Medical reports positive results from pilot PK study of innovative oral GLP-1 agonist weight loss tablet, LXM.2 ...

US FDA clears expanded use of Alcresta Therapeutics’ RELiZORB cartridge for paediatric patients 1 year of age and older: Waltham, Massachusetts Friday, January 17, 2025, 17:00 H ...

KL Krems & MedUni Vienna study provides new insights into the genetic mechanisms of birch pollen allergy: Krems, Austria Friday, January 17, 2025, 16:00 Hrs [IST] An innovative st ...

Industry hails CDSCO's decision not to allow import of refurbished medical devices to India: Our Bureau, New Delhi Friday, January 17, 2025, 16:45 Hrs [IST] The industry and healt ...

MTaI seeks reducing customs duty on devices without alternatives available in India: Our Bureau, New Delhi Friday, January 17, 2025, 15:50 Hrs [IST] Medical Technology Association ...

DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a pilot proteomics programme to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, ...

The Directorate General of Trade Remedies (DGTR) has issued an updated notification concerning the ongoing anti-dumping investigation into imports of Resorcinol from China PR and Japan. The ...

The Punjab Drug Manufacturers Association (PDMA) has sought the Union ministry of health and family welfare to create a separate category for units below Rs. 10 crore turnover outside the erstwhile ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients ...

India’s pharmaceutical exporters are on edge as they await a decisive response from the government regarding their long pending appeal for relief under the restrictive payment conditions of Section ...

Harbour BioMed, a global biopharmaceutical company, announced that the company and Sichuan Kelun Biotech BioPharmaceutical have entered into a license agreement with Windward Bio AG (Windward Bio) for ...